PLANT ORIGINAL: Cimicifuga Racemosa
PART USED：Root
SPECIFICATION: Triterpene Glycosides2.5% 5% 8% Test By HPLC
MOLECULAR STRUCTURE:

Cimicifugoside



Cimiracemodide


INDICATIONS:
It was used to treat joint, muscle and nerve pain rheumatism and menopause. And is approved for treatment of premenstrual syndrome and dysmenorrhea (painful menstruation) and for menopausal symptoms.